Dr. Cui has 18 years’ working experience in pharmaceutical industry in US and China. He obtained his BS and MS degrees from China Pharmaceutical University (1991 and 1994) and worked there for five years before attending Ohio State University for his PhD training (1999-2003). After graduation Dr. Cui joined Vertex Pharmaceuticals (Boston) as a formulation scientist (2003-2005). He then moved to Genentech as a formulation scientist and later moved up to become a Group Leader/Senior Scientist (2005-2013). In 2013 Dr. Cui joined Hisun-Pfizer Pharmaceuticals (Shanghai) as a Director of Formulation Development. In 2015 he joined Qilu Pharmaceuticals (Hainan) as a Vice President of R&D and Business Development of US.
Dr. Cui’s experience covers both new chemical entities and generic products. He is the lead pharmaceutical scientist for two successful NDAs in the US, and has been involved in multiple interactions with the US FDA. He has been an invited expert by China FDA since 2012. Dr. Cui’s research interests include late-stage drug product development and pharmaceutical material science. He has authored or co-authored 20 publications.